MARIANGELA MARTINELLI: Open Payments
NPI 1285062612 · WESTMINSTER, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,539 in 179 payments from 22 companies in 2025. Trend: 2023 $3,963 · 2024 $4,649 · 2025 $4,539
Food & beverage: $4,358Education: $181
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $781 |
| GlaxoSmithKline, LLC. | 27 | $502 |
| Viatris Specialty LLC | 18 | $438 |
| JAZZ PHARMACEUTICALS INC. | 22 | $424 |
| Mallinckrodt Hospital Products Inc. | 13 | $377 |
| Verona Pharma, Inc. | 15 | $316 |
| GENZYME CORPORATION | 14 | $296 |
| Axsome Therapeutics, Inc. | 13 | $259 |
| Regeneron Healthcare Solutions, Inc. | 9 | $213 |
| Avadel CNS Pharmaceuticals, LLC | 4 | $192 |
Products named: DUPIXENT, YUPELRI, AIRSUPRA, XYWAV, NUCALA, ACTHAR, FASENRA, Ohtuvayre.
Industry payments across MD — which companies pay providers there.
